Cargando…
Abiraterone Acetate Withdrawal Syndrome: Does It Exist?
In 2011 abiraterone acetate (AA) was approved for the treatment of castrate-resistant metastatic prostate cancer patients who have failed docetaxel chemotherapy. We report the case of a patient who experienced a confirmed PSA decrease of ≤50% after stopping AA, mimicking an antiandrogen withdrawal s...
Autores principales: | Gauthier, Hélène, Bousquet, Guilhem, Pouessel, Damien, Culine, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409514/ https://www.ncbi.nlm.nih.gov/pubmed/23525261 http://dx.doi.org/10.1159/000341564 |
Ejemplares similares
-
Very Fast Recovery of Acute Disseminated Intravascular Coagulation with Abiraterone Acetate in a Patient with Bone Metastases from Castrate-Resistant Prostate Cancer
por: Gauthier, Hélène, et al.
Publicado: (2014) -
Hypertropia following Spontaneous Resolution of Brown's Syndrome
por: Kent, Jerrod S., et al.
Publicado: (2012) -
Complicated Cholelithiasis: An Unusual Combination of Acute Pancreatitis and Bouveret Syndrome
por: Baloyiannis, Ioannis, et al.
Publicado: (2012) -
Rituximab Treatment for PR3-ANCA-Positive Membranoproliferative Glomerulonephritis Associated with Adult-Onset Periodic Fever Syndrome
por: Hamano, Yoshitomo, et al.
Publicado: (2012) -
Chylous Ascites Secondary to Giant Liver Hemangioma
por: Lazarus, Darius L., et al.
Publicado: (2012)